These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 536276)

  • 61. Combination vincristine and VP-16-213: evaluation of drug sequence.
    Jackson DV; Long TR; Rice DG; Morgan TM
    Cancer Biochem Biophys; 1986 Oct; 8(4):265-75. PubMed ID: 3802048
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative study of in vivo development of resistance to various classes of antitumor agents in P388 leukemia.
    Inaba M; Fujikura R; Sakurai Y
    Gan; 1979 Oct; 70(5):607-13. PubMed ID: 520752
    [No Abstract]   [Full Text] [Related]  

  • 63. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 65. Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid.
    Zunino F; Giuliani F; Savi G; Dasdia T; Gambetta R
    Int J Cancer; 1982 Oct; 30(4):465-70. PubMed ID: 7141741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
    Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Use of hexaphosphamide for the treatment of myelocytic leukemia].
    Nevskaia TP; Levitin EI; Mokeeva RA; Faĭnshteĭn FE
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):57. PubMed ID: 1071794
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
    Machida S; Ito Y; Hoshino A
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [14Co-dimetinur distribution in mice in relation to the stage of the development of tumor process].
    Ostrovskaia LA; Rykova VA; Kondarov AA; Etvesh L; Shimon-Trompler E; Sokolova IS; Korman DB
    Eksp Onkol; 1990; 12(1):70-4. PubMed ID: 2298149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of vitamins C and B12 on the survival rate of mice bearing ascites tumor.
    Poydock ME; Reikert D; Rice J
    Exp Cell Biol; 1982; 50(2):88-91. PubMed ID: 7075860
    [No Abstract]   [Full Text] [Related]  

  • 71. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
    Frankfurt OS
    J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
    Marsh JC; Shoemaker RH; Suffness M
    Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
    Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
    Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
    Basrur VS; Chitnis MP; Menon RS
    Oncology; 1983; 40(3):202-4. PubMed ID: 6843944
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitrotriazole AK-2123 enhances mitomycin C activity in mice bearing multidrug-resistant tumors.
    Goncharova SA; Rajewskaya TA; Konovalova NP; Kagiya TV
    J Chemother; 2001 Dec; 13(6):635-40. PubMed ID: 11806625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 77. Therapeutic effects of BM 12,531 (Prop. INN azimexon).
    Bicker U
    Recent Results Cancer Res; 1980; 75():147-52. PubMed ID: 7232826
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cyclic acetal derivatives of mitomycin C.
    Kaneko T; Wong H; Rose WC; Bradner WT; Doyle TW
    J Antibiot (Tokyo); 1990 Jan; 43(1):122-4. PubMed ID: 2307625
    [No Abstract]   [Full Text] [Related]  

  • 79. Antileukemic activity of 2-bis(2-methylthio)vinyl-1-methylquinolinium iodides.
    Foye WO; Kauffman JM
    J Pharm Sci; 1980 Apr; 69(4):477-80. PubMed ID: 6929335
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The radioenhancement effects of 5-thio-D-glucose and insulin in vivo on a hypoxic P388 murine leukemia.
    Belgrad R; Wampler GL; Hazra T
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):713-6. PubMed ID: 6343313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.